The problem of atrophic vaginitis (AV) in postmenopause is widespread; it is considered a natural aging process and is currently not solved. To ensure the proliferation of multilayer squamous epithelium for the formation of vaginal resistance to infection in postmenopausal, local estrogen therapy is performed. Before restoring the functions of the vagina with estrogen preparations, preliminary sanitation is advisable. The appearance on the market of combined drugs with antimicrobial and fungicidal action requires the development of schemes for their effective use
Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therap
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical ...
Herein, joint recommendations for diagnosis and treatment of vulvo-vaginal atrophy (VVA) in women in...
The problem of atrophic vaginitis (AV) in postmenopause is widespread; it is considered a natural ag...
Background: Due to the defficiency of sex hormone estrogen after the menopause, the quality of woman...
Unlike hot flushes and night sweats which resolve spontaneously in time, atrophic symptoms affecting...
Vulvovaginal atrophy (VVA) is a silent epidemic that affects up to 50%-60% of postmenopausal women w...
The objective: to evaluate the clinical effectiveness of treatment of atrophic vaginitis in menopaus...
Mary Jane Minkin,1 Ricardo Maamari,2 Suzanne Reiter3 1Department of Gynecology and Reproductive Medi...
OBJECTIVE: To update and expand the previous position statement of The North American Menopause Soci...
Due to the increase in life expectancy, today, most women live in a state of estrogen deficiency for...
The article is devoted to the problem of restoring the physiological conditions of vaginal contents ...
Data are presented on the stages of aging of the female reproductive system and the symptoms develop...
PURPOSE OF INVESTIGATION: To verify the effectiveness and safety of low-dose 17beta-estradiol vagina...
Introduction: Vulvovaginal atrophy (VVA) is a chronic condition caused by estrogen deficiency. It af...
Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therap
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical ...
Herein, joint recommendations for diagnosis and treatment of vulvo-vaginal atrophy (VVA) in women in...
The problem of atrophic vaginitis (AV) in postmenopause is widespread; it is considered a natural ag...
Background: Due to the defficiency of sex hormone estrogen after the menopause, the quality of woman...
Unlike hot flushes and night sweats which resolve spontaneously in time, atrophic symptoms affecting...
Vulvovaginal atrophy (VVA) is a silent epidemic that affects up to 50%-60% of postmenopausal women w...
The objective: to evaluate the clinical effectiveness of treatment of atrophic vaginitis in menopaus...
Mary Jane Minkin,1 Ricardo Maamari,2 Suzanne Reiter3 1Department of Gynecology and Reproductive Medi...
OBJECTIVE: To update and expand the previous position statement of The North American Menopause Soci...
Due to the increase in life expectancy, today, most women live in a state of estrogen deficiency for...
The article is devoted to the problem of restoring the physiological conditions of vaginal contents ...
Data are presented on the stages of aging of the female reproductive system and the symptoms develop...
PURPOSE OF INVESTIGATION: To verify the effectiveness and safety of low-dose 17beta-estradiol vagina...
Introduction: Vulvovaginal atrophy (VVA) is a chronic condition caused by estrogen deficiency. It af...
Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therap
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical ...
Herein, joint recommendations for diagnosis and treatment of vulvo-vaginal atrophy (VVA) in women in...